Top Markets
Coin of the day
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

SOAGY
株式のランク #317
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and... Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
株価
$47.54
時価総額
$69.46B
変化(1日)
-3.59%
変化(1年)
-9.07%
DE
取引 Sartorius Aktiengesellschaft (SOAGY)

カテゴリー

Sartorius Aktiengesellschaft(SOAGY)のP/E比率
March 2026 時点のP/E比率 TTM 107.05
Sartorius Aktiengesellschaft の最新の財務報告および株価によると、現在の P/E (TTM) は 107.05 です。2023 年末時点での P/E は 115.13 でした。
Sartorius Aktiengesellschaft の P/E 比率の履歴(2002 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 107.05 -39.42%
2024 176.71 53.49%
2023 115.13 315.95%
2022 27.68 -70.98%
2021 95.37 30.42%
2020 73.13 22.59%
2019 59.65 12.80%
2018 52.88 10.69%
2017 47.78 2.00%
2016 46.84 44.32%
2015 32.46 -8.75%
2014 35.57 26.42%
2013 28.13 16.57%
2012 24.14 110.44%
2011 11.47 -23.94%
2010 15.08 -94.58%
2009 278.35 3,158.24%
2008 8.54 -43.48%
2007 15.12 -20.87%
2006 19.10 20.76%
2005 15.82 -7.24%
2004 17.05 -33.05%
2003 25.47 79.68%
2002 14.18 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
62.57 -41.55%
US
28.63 -73.25%
US
38.22 -64.30%
JP
43.53 -59.34%
CH
25.26 -76.40%
US
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。